Metropolis Healthcare Introduces Comprehensive Cancer Screen 360, Pioneering Strides in Proactive Cancer Detection Across India
Metropolis Healthcare Limited, led by Ameera Shah, unveils revolutionary cancer screening panel
Metropolis Healthcare Limited, India's second-largest diagnostic laboratory chain, has announced the launch of TruHealth Cancer Screen 360, a comprehensive screening panel aimed at strengthening preventive oncology in the country. This innovative offering is a first-of-its-kind initiative in the Indian diagnostics space.
The TruHealth Cancer Screen 360 includes gender-specific screening modules for early detection of various cancers, such as breast, ovarian, cervical, liver, lung, prostate, colorectal, and thyroid cancers. The panel combines tumor markers, hereditary cancer risk analysis, and organ-specific assessments in a three-layered screening approach.
In particular, the gender-specific profiles cater to the unique needs of men and women. The female profile incorporates HPV self-sampling for cervical cancer and hereditary cancer panels (BRCA1/2, among others), while the male profile includes PSA testing for prostate cancer. These features aim to equip both clinicians and individuals with critical, actionable information.
Metropolis Healthcare's commitment to affordable and inclusive specialized cancer diagnostics is further demonstrated through the introductory price of the TruHealth Cancer Screen 360. Priced below the combined cost of individual tests, the advanced screening solution is made widely available across the company's national network.
Commenting on the launch, Surendran Chemmenkottil, CEO of Metropolis Healthcare Ltd., stated, "The introduction of TruHealth Cancer Screen 360 reflects our unwavering commitment to strengthening preventive healthcare in India. By equipping individuals with timely and reliable diagnostic tools, we aim to empower them to take charge of their health."
With cancer remaining a major global health concern and India ranking third in terms of cancer incidence in the South-East Asia region, the TruHealth Cancer Screen 360 is poised to bridge diagnostic gaps and lower the burden of late-stage cancer. According to the World Health Organization, India's screening coverage for cervical, breast, and oral cancers is significantly below the 70% target for cervical cancer screening.
As the country grapples with growing cancer incidence, targeted cancer screening integrated into routine health check-ups becomes increasingly essential. Dr. Kirti Chadha, Senior Oncopathologist and Chief Scientific and Innovation Officer at Metropolis Healthcare Ltd., explained that the TruHealth Cancer Screen 360 has been developed as an evidence-based, comprehensive tool that goes beyond general wellness testing. By incorporating a broad spectrum of biomarkers and hereditary risk indicators, it facilitates early identification of cancer risks, even before symptoms appear.
Key features of the TruHealth Cancer Screen 360 include free genetic counseling with certified counselors to support individuals in understanding results and next steps. The panel's affordability and accessibility, along with actionable insights it provides, empower patients to take proactive steps in managing their health while promoting awareness about the importance of cancer screening.
Founded in 1981, Metropolis Healthcare Limited is India's second-largest diagnostic chain, recognized for delivering best-in-class diagnostic services across the country. The company's extensive footprint, comprising over 210 laboratories, 4,500 patient service centers, and more than 10,000 touchpoints, demonstrates its commitment to quality and accessibility. With a robust portfolio of over 4,000 tests and profiles, Metropolis continues to lead diagnostic innovation, driving early diagnosis, clinical excellence, and preventive healthcare for all.
- Metropolis Healthcare Limited, in its pursuit of driving preventive healthcare and diagnostic innovation, has launched TruHealth Cancer Screen 360 - a revolutionary cancer screening panel that combines science, innovation, and healthcare to strengthen preventive oncology.
- This comprehensive screening panel, a pioneer in the Indian diagnostics space, includes gender-specific modules for early detection of multiple medical-conditions such as breast, ovarian, cervical, liver, lung, prostate, colorectal, thyroid cancers, and more.
- As a commitment to making cancer screening accessible and affordable, Metropolis Healthcare has priced the advanced TruHealth Cancer Screen 360 below the combined cost of individual tests, ensuring its availability across the nation and contributing significantly to health-and-wellness initiatives in India.
